APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Fingolimod

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Fingolimod Market Analysis and Forecast 2026-2032

Report ID 173991940226 December 2025191 pages

Choose your research edition.

Industry ResearchFingolimod Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Fingolimod Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Fingolimod Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Fingolimod Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Fingolimod Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Fingolimod market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Fingolimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Fingolimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Fingolimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Fingolimod is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Fingolimod include Novartis, AstraZeneca, Pharmacor, PharmaCompass, Gilenya, Dr. Reddy's Laboratories, BNF - NICE and Arrow, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Fingolimod, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Fingolimod, also provides the sales of main regions and countries. Of the upcoming market potential for Fingolimod, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Fingolimod sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Fingolimod market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Fingolimod sales, projected growth trends, production technology, application and end-user industry.

Fingolimod Segment by Company

Novartis

AstraZeneca

Pharmacor

PharmaCompass

Gilenya

Dr. Reddy's Laboratories

BNF - NICE

Arrow

Fingolimod Segment by Type

Oral

Injection

Fingolimod Segment by Application

Medical Field

Science Research Field

Other Fields

Fingolimod Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fingolimod market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Fingolimod and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fingolimod.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Fingolimod in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Fingolimod manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fingolimod sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Fingolimod Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Oral Major Manufacturers Table 3. Injection Major Manufacturers Table 4. Global Fingolimod Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Medical Field Major Manufacturers Table 6. Science Research Field Major Manufacturers Table 7. Other Fields Major Manufacturers Table 8. Fingolimod Industry Trends Table 9. Fingolimod Industry Drivers Table 10. Fingolimod Industry Opportunities and Challenges Table 11. Fingolimod Industry Restraints Table 12. Global Fingolimod Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Fingolimod Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Fingolimod Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Fingolimod Revenue Market Share by Region (2021-2026) Table 16. Global Fingolimod Revenue Market Share by Region (2027-2032) Table 17. Global Fingolimod Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Tons) Table 18. Global Fingolimod Sales by Region (2021-2026) & (Tons) Table 19. Global Fingolimod Sales by Region (2027-2032) & (Tons) Table 20. Global Fingolimod Sales Market Share by Region (2021-2026) Table 21. Global Fingolimod Sales Market Share by Region (2027-2032) Table 22. Global Fingolimod Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Fingolimod Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Fingolimod Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Fingolimod Sales Market Share by Manufacturers (2021-2026) Table 26. Global Fingolimod Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 27. Global Fingolimod Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Fingolimod Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Fingolimod Manufacturers, Product Type & Application Table 30. Global Fingolimod Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Fingolimod by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Fingolimod Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Fingolimod Revenue Market Share by Type (2021-2026) Table 37. Global Fingolimod Revenue Market Share by Type (2027-2032) Table 38. Global Fingolimod Sales by Type 2021 VS 2025 VS 2032 (Tons) Table 39. Global Fingolimod Sales by Type (2021-2026) & (Tons) Table 40. Global Fingolimod Sales by Type (2027-2032) & (Tons) Table 41. Global Fingolimod Sales Market Share by Type (2021-2026) Table 42. Global Fingolimod Sales Market Share by Type (2027-2032) Table 43. Global Fingolimod Price by Type (2021-2026) & (US$/Ton) Table 44. Global Fingolimod Price by Type (2027-2032) & (US$/Ton) Table 45. Global Fingolimod Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Fingolimod Revenue Market Share by Application (2021-2026) Table 49. Global Fingolimod Revenue Market Share by Application (2027-2032) Table 50. Global Fingolimod Sales by Application 2021 VS 2025 VS 2032 (Tons) Table 51. Global Fingolimod Sales by Application (2021-2026) & (Tons) Table 52. Global Fingolimod Sales by Application (2027-2032) & (Tons) Table 53. Global Fingolimod Sales Market Share by Application (2021-2026) Table 54. Global Fingolimod Sales Market Share by Application (2027-2032) Table 55. Global Fingolimod Price by Application (2021-2026) & (US$/Ton) Table 56. Global Fingolimod Price by Application (2027-2032) & (US$/Ton) Table 57. Novartis Company Information Table 58. Novartis Business Overview Table 59. Novartis Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Novartis Fingolimod Product Portfolio Table 61. Novartis Recent Development Table 62. AstraZeneca Company Information Table 63. AstraZeneca Business Overview Table 64. AstraZeneca Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. AstraZeneca Fingolimod Product Portfolio Table 66. AstraZeneca Recent Development Table 67. Pharmacor Company Information Table 68. Pharmacor Business Overview Table 69. Pharmacor Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Pharmacor Fingolimod Product Portfolio Table 71. Pharmacor Recent Development Table 72. PharmaCompass Company Information Table 73. PharmaCompass Business Overview Table 74. PharmaCompass Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. PharmaCompass Fingolimod Product Portfolio Table 76. PharmaCompass Recent Development Table 77. Gilenya Company Information Table 78. Gilenya Business Overview Table 79. Gilenya Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Gilenya Fingolimod Product Portfolio Table 81. Gilenya Recent Development Table 82. Dr. Reddy's Laboratories Company Information Table 83. Dr. Reddy's Laboratories Business Overview Table 84. Dr. Reddy's Laboratories Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Dr. Reddy's Laboratories Fingolimod Product Portfolio Table 86. Dr. Reddy's Laboratories Recent Development Table 87. BNF - NICE Company Information Table 88. BNF - NICE Business Overview Table 89. BNF - NICE Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. BNF - NICE Fingolimod Product Portfolio Table 91. BNF - NICE Recent Development Table 92. Arrow Company Information Table 93. Arrow Business Overview Table 94. Arrow Fingolimod Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Arrow Fingolimod Product Portfolio Table 96. Arrow Recent Development Table 97. North America Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 98. North America Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 99. North America Fingolimod Sales by Type (2021-2026) & (Tons) Table 100. North America Fingolimod Sales by Type (2027-2032) & (Tons) Table 101. North America Fingolimod Sales Price by Type (2021-2026) & (US$/Ton) Table 102. North America Fingolimod Sales Price by Type (2027-2032) & (US$/Ton) Table 103. North America Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 104. North America Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 105. North America Fingolimod Sales by Application (2021-2026) & (Tons) Table 106. North America Fingolimod Sales by Application (2027-2032) & (Tons) Table 107. North America Fingolimod Sales Price by Application (2021-2026) & (US$/Ton) Table 108. North America Fingolimod Sales Price by Application (2027-2032) & (US$/Ton) Table 109. North America Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Fingolimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 111. North America Fingolimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 112. North America Fingolimod Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 113. North America Fingolimod Sales by Country (2021-2026) & (Tons) Table 114. North America Fingolimod Sales by Country (2027-2032) & (Tons) Table 115. North America Fingolimod Sales Price by Country (2021-2026) & (US$/Ton) Table 116. North America Fingolimod Sales Price by Country (2027-2032) & (US$/Ton) Table 117. United States Fingolimod Revenue (2021-2032) & (US$ Million) Table 118. Canada Fingolimod Revenue (2021-2032) & (US$ Million) Table 119. Mexico Fingolimod Revenue (2021-2032) & (US$ Million) Table 120. Europe Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Fingolimod Sales by Type (2021-2026) & (Tons) Table 123. Europe Fingolimod Sales by Type (2027-2032) & (Tons) Table 124. Europe Fingolimod Sales Price by Type (2021-2026) & (US$/Ton) Table 125. Europe Fingolimod Sales Price by Type (2027-2032) & (US$/Ton) Table 126. Europe Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Fingolimod Sales by Application (2021-2026) & (Tons) Table 129. Europe Fingolimod Sales by Application (2027-2032) & (Tons) Table 130. Europe Fingolimod Sales Price by Application (2021-2026) & (US$/Ton) Table 131. Europe Fingolimod Sales Price by Application (2027-2032) & (US$/Ton) Table 132. Europe Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Fingolimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Fingolimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Fingolimod Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 136. Europe Fingolimod Sales by Country (2021-2026) & (Tons) Table 137. Europe Fingolimod Sales by Country (2027-2032) & (Tons) Table 138. Europe Fingolimod Sales Price by Country (2021-2026) & (US$/Ton) Table 139. Europe Fingolimod Sales Price by Country (2027-2032) & (US$/Ton) Table 140. Germany Fingolimod Revenue (2021-2032) & (US$ Million) Table 141. France Fingolimod Revenue (2021-2032) & (US$ Million) Table 142. U.K. Fingolimod Revenue (2021-2032) & (US$ Million) Table 143. Italy Fingolimod Revenue (2021-2032) & (US$ Million) Table 144. Russia Fingolimod Revenue (2021-2032) & (US$ Million) Table 145. Spain Fingolimod Revenue (2021-2032) & (US$ Million) Table 146. Netherlands Fingolimod Revenue (2021-2032) & (US$ Million) Table 147. Switzerland Fingolimod Revenue (2021-2032) & (US$ Million) Table 148. Sweden Fingolimod Revenue (2021-2032) & (US$ Million) Table 149. Poland Fingolimod Revenue (2021-2032) & (US$ Million) Table 150. China Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 151. China Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 152. China Fingolimod Sales by Type (2021-2026) & (Tons) Table 153. China Fingolimod Sales by Type (2027-2032) & (Tons) Table 154. China Fingolimod Sales Price by Type (2021-2026) & (US$/Ton) Table 155. China Fingolimod Sales Price by Type (2027-2032) & (US$/Ton) Table 156. China Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 157. China Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 158. China Fingolimod Sales by Application (2021-2026) & (Tons) Table 159. China Fingolimod Sales by Application (2027-2032) & (Tons) Table 160. China Fingolimod Sales Price by Application (2021-2026) & (US$/Ton) Table 161. China Fingolimod Sales Price by Application (2027-2032) & (US$/Ton) Table 162. Asia Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 163. Asia Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 164. Asia Fingolimod Sales by Type (2021-2026) & (Tons) Table 165. Asia Fingolimod Sales by Type (2027-2032) & (Tons) Table 166. Asia Fingolimod Sales Price by Type (2021-2026) & (US$/Ton) Table 167. Asia Fingolimod Sales Price by Type (2027-2032) & (US$/Ton) Table 168. Asia Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 169. Asia Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 170. Asia Fingolimod Sales by Application (2021-2026) & (Tons) Table 171. Asia Fingolimod Sales by Application (2027-2032) & (Tons) Table 172. Asia Fingolimod Sales Price by Application (2021-2026) & (US$/Ton) Table 173. Asia Fingolimod Sales Price by Application (2027-2032) & (US$/Ton) Table 174. Asia Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 175. Asia Fingolimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 176. Asia Fingolimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 177. Asia Fingolimod Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 178. Asia Fingolimod Sales by Country (2021-2026) & (Tons) Table 179. Asia Fingolimod Sales by Country (2027-2032) & (Tons) Table 180. Asia Fingolimod Sales Price by Country (2021-2026) & (US$/Ton) Table 181. Asia Fingolimod Sales Price by Country (2027-2032) & (US$/Ton) Table 182. Japan Fingolimod Revenue (2021-2032) & (US$ Million) Table 183. South Korea Fingolimod Revenue (2021-2032) & (US$ Million) Table 184. India Fingolimod Revenue (2021-2032) & (US$ Million) Table 185. Australia Fingolimod Revenue (2021-2032) & (US$ Million) Table 186. Taiwan Fingolimod Revenue (2021-2032) & (US$ Million) Table 187. Southeast Asia Fingolimod Revenue (2021-2032) & (US$ Million) Table 188. SAMEA Fingolimod Revenue by Type (2021-2026) & (US$ Million) Table 189. SAMEA Fingolimod Revenue by Type (2027-2032) & (US$ Million) Table 190. SAMEA Fingolimod Sales by Type (2021-2026) & (Tons) Table 191. SAMEA Fingolimod Sales by Type (2027-2032) & (Tons) Table 192. SAMEA Fingolimod Sales Price by Type (2021-2026) & (US$/Ton) Table 193. SAMEA Fingolimod Sales Price by Type (2027-2032) & (US$/Ton) Table 194. SAMEA Fingolimod Revenue by Application (2021-2026) & (US$ Million) Table 195. SAMEA Fingolimod Revenue by Application (2027-2032) & (US$ Million) Table 196. SAMEA Fingolimod Sales by Application (2021-2026) & (Tons) Table 197. SAMEA Fingolimod Sales by Application (2027-2032) & (Tons) Table 198. SAMEA Fingolimod Sales Price by Application (2021-2026) & (US$/Ton) Table 199. SAMEA Fingolimod Sales Price by Application (2027-2032) & (US$/Ton) Table 200. SAMEA Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 201. SAMEA Fingolimod Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 202. SAMEA Fingolimod Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 203. SAMEA Fingolimod Sales by Country (2021 VS 2025 VS 2032) & (Tons) Table 204. SAMEA Fingolimod Sales by Country (2021-2026) & (Tons) Table 205. SAMEA Fingolimod Sales by Country (2027-2032) & (Tons) Table 206. SAMEA Fingolimod Sales Price by Country (2021-2026) & (US$/Ton) Table 207. SAMEA Fingolimod Sales Price by Country (2027-2032) & (US$/Ton) Table 208. Brazil Fingolimod Revenue (2021-2032) & (US$ Million) Table 209. Argentina Fingolimod Revenue (2021-2032) & (US$ Million) Table 210. Chile Fingolimod Revenue (2021-2032) & (US$ Million) Table 211. Colombia Fingolimod Revenue (2021-2032) & (US$ Million) Table 212. Peru Fingolimod Revenue (2021-2032) & (US$ Million) Table 213. Saudi Arabia Fingolimod Revenue (2021-2032) & (US$ Million) Table 214. Israel Fingolimod Revenue (2021-2032) & (US$ Million) Table 215. UAE Fingolimod Revenue (2021-2032) & (US$ Million) Table 216. Turkey Fingolimod Revenue (2021-2032) & (US$ Million) Table 217. Iran Fingolimod Revenue (2021-2032) & (US$ Million) Table 218. Egypt Fingolimod Revenue (2021-2032) & (US$ Million) Table 219. Key Raw Materials Table 220. Raw Materials Key Suppliers Table 221. Fingolimod Distributors List Table 222. Fingolimod Customers List Table 223. Research Programs/Design for This Report Table 224. Authors List of This Report Table 225. Secondary Sources Table 226. Primary Sources List of Figures Figure 1. Fingolimod Image Figure 2. Global Fingolimod Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Fingolimod Market Size Share 2021 VS 2025 VS 2032 Figure 4. Oral Image Figure 5. Injection Image Figure 6. Global Fingolimod Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Fingolimod Market Size Share 2021 VS 2025 VS 2032 Figure 8. Medical Field Image Figure 9. Science Research Field Image Figure 10. Other Fields Image Figure 11. Global Fingolimod Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Fingolimod Revenue (2021-2032) & (US$ Million) Figure 13. Global Fingolimod Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Fingolimod Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Fingolimod Revenue Market Share by Region (2021-2032) Figure 16. Global Fingolimod Sales (2021-2032) & (Tons) Figure 17. Global Fingolimod Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 18. Global Fingolimod Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Fingolimod Sales YoY (2021-2032) & (Tons) Figure 20. Europe Fingolimod Sales YoY (2021-2032) & (Tons) Figure 21. China Fingolimod Sales YoY (2021-2032) & (Tons) Figure 22. Asia (Excluding China) Fingolimod Sales YoY (2021-2032) & (Tons) Figure 23. South America, Middle East and Africa Fingolimod Sales YoY (2021-2032) & (Tons) Figure 24. Global Fingolimod Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Fingolimod Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Fingolimod Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Fingolimod Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Fingolimod Revenue Market Share by Type (2021-2032) Figure 30. Global Fingolimod Sales by Type (2021 VS 2025 VS 2032) & (Tons) Figure 31. Global Fingolimod Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Fingolimod Sales Market Share by Type (2021-2032) Figure 33. Global Fingolimod Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Fingolimod Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Fingolimod Revenue Market Share by Application (2021-2032) Figure 36. Global Fingolimod Sales by Application (2021 VS 2025 VS 2032) & (Tons) Figure 37. Global Fingolimod Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Fingolimod Sales Market Share by Application (2021-2032) Figure 39. North America Fingolimod Revenue Share by Type (2021-2032) Figure 40. North America Fingolimod Sales Share by Type (2021-2032) Figure 41. North America Fingolimod Revenue Share by Application (2021-2032) Figure 42. North America Fingolimod Sales Share by Application (2021-2032) Figure 43. North America Fingolimod Revenue Share by Country (2021-2032) Figure 44. North America Fingolimod Sales Share by Country (2021-2032) Figure 45. Europe Fingolimod Revenue Share by Type (2021-2032) Figure 46. Europe Fingolimod Sales Share by Type (2021-2032) Figure 47. Europe Fingolimod Revenue Share by Application (2021-2032) Figure 48. Europe Fingolimod Sales Share by Application (2021-2032) Figure 49. Europe Fingolimod Revenue Share by Country (2021-2032) Figure 50. Europe Fingolimod Sales Share by Country (2021-2032) Figure 51. China Fingolimod Revenue Share by Type (2021-2032) Figure 52. China Fingolimod Sales Share by Type (2021-2032) Figure 53. China Fingolimod Revenue Share by Application (2021-2032) Figure 54. China Fingolimod Sales Share by Application (2021-2032) Figure 55. Asia Fingolimod Revenue Share by Type (2021-2032) Figure 56. Asia Fingolimod Sales Share by Type (2021-2032) Figure 57. Asia Fingolimod Revenue Share by Application (2021-2032) Figure 58. Asia Fingolimod Sales Share by Application (2021-2032) Figure 59. Asia Fingolimod Revenue Share by Country (2021-2032) Figure 60. Asia Fingolimod Sales Share by Country (2021-2032) Figure 61. SAMEA Fingolimod Revenue Share by Type (2021-2032) Figure 62. SAMEA Fingolimod Sales Share by Type (2021-2032) Figure 63. SAMEA Fingolimod Revenue Share by Application (2021-2032) Figure 64. SAMEA Fingolimod Sales Share by Application (2021-2032) Figure 65. SAMEA Fingolimod Revenue Share by Country (2021-2032) Figure 66. SAMEA Fingolimod Sales Share by Country (2021-2032) Figure 67. Fingolimod Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Fingolimod Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Medical Field
  • Science Research Field
  • Other Fields
Companies covered
  • Novartis
  • AstraZeneca
  • Pharmacor
  • PharmaCompass
  • Gilenya
  • Dr. Reddy's Laboratories
  • BNF - NICE
  • Arrow

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Fingolimod Market by Type
  3. 1.2.1 Global Fingolimod Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Oral
  5. 1.2.3 Injection
  6. 1.3 Fingolimod Market by Application
  7. 1.3.1 Global Fingolimod Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Medical Field
  9. 1.3.3 Science Research Field
  10. 1.3.4 Other Fields
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Fingolimod Market Dynamics
  1. 2.1 Fingolimod Industry Trends
  2. 2.2 Fingolimod Industry Drivers
  3. 2.3 Fingolimod Industry Opportunities and Challenges
  4. 2.4 Fingolimod Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Fingolimod Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Fingolimod Revenue by Region
  3. 3.2.1 Global Fingolimod Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Fingolimod Revenue by Region (2021-2026)
  5. 3.2.3 Global Fingolimod Revenue by Region (2027-2032)
  6. 3.2.4 Global Fingolimod Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Fingolimod Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Fingolimod Sales by Region
  9. 3.4.1 Global Fingolimod Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Fingolimod Sales by Region (2021-2026)
  11. 3.4.3 Global Fingolimod Sales by Region (2027-2032)
  12. 3.4.4 Global Fingolimod Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Fingolimod Revenue by Manufacturers
  2. 4.1.1 Global Fingolimod Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Fingolimod Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Fingolimod Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Fingolimod Sales by Manufacturers
  6. 4.2.1 Global Fingolimod Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Fingolimod Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Fingolimod Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Fingolimod Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Fingolimod Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Fingolimod Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Fingolimod Manufacturers, Product Type & Application
  13. 4.7 Global Fingolimod Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Fingolimod Market CR5 and HHI
  16. 4.8.2 2025 Fingolimod Tier 1, Tier 2, and Tier 3
5 Fingolimod Market by Type
  1. 5.1 Global Fingolimod Revenue by Type
  2. 5.1.1 Global Fingolimod Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Fingolimod Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Fingolimod Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Fingolimod Sales by Type
  6. 5.2.1 Global Fingolimod Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Fingolimod Sales by Type (2021-2032) & (Tons)
  8. 5.2.3 Global Fingolimod Sales Market Share by Type (2021-2032)
  9. 5.3 Global Fingolimod Price by Type
6 Fingolimod Market by Application
  1. 6.1 Global Fingolimod Revenue by Application
  2. 6.1.1 Global Fingolimod Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Fingolimod Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Fingolimod Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Fingolimod Sales by Application
  6. 6.2.1 Global Fingolimod Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Fingolimod Sales by Application (2021-2032) & (Tons)
  8. 6.2.3 Global Fingolimod Sales Market Share by Application (2021-2032)
  9. 6.3 Global Fingolimod Price by Application
7 Company Profiles
  1. 7.1 Novartis
  2. 7.1.1 Novartis Company Information
  3. 7.1.2 Novartis Business Overview
  4. 7.1.3 Novartis Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Fingolimod Product Portfolio
  6. 7.1.5 Novartis Recent Developments
  7. 7.2 AstraZeneca
  8. 7.2.1 AstraZeneca Company Information
  9. 7.2.2 AstraZeneca Business Overview
  10. 7.2.3 AstraZeneca Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Fingolimod Product Portfolio
  12. 7.2.5 AstraZeneca Recent Developments
  13. 7.3 Pharmacor
  14. 7.3.1 Pharmacor Company Information
  15. 7.3.2 Pharmacor Business Overview
  16. 7.3.3 Pharmacor Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pharmacor Fingolimod Product Portfolio
  18. 7.3.5 Pharmacor Recent Developments
  19. 7.4 PharmaCompass
  20. 7.4.1 PharmaCompass Company Information
  21. 7.4.2 PharmaCompass Business Overview
  22. 7.4.3 PharmaCompass Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 PharmaCompass Fingolimod Product Portfolio
  24. 7.4.5 PharmaCompass Recent Developments
  25. 7.5 Gilenya
  26. 7.5.1 Gilenya Company Information
  27. 7.5.2 Gilenya Business Overview
  28. 7.5.3 Gilenya Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Gilenya Fingolimod Product Portfolio
  30. 7.5.5 Gilenya Recent Developments
  31. 7.6 Dr. Reddy's Laboratories
  32. 7.6.1 Dr. Reddy's Laboratories Company Information
  33. 7.6.2 Dr. Reddy's Laboratories Business Overview
  34. 7.6.3 Dr. Reddy's Laboratories Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Dr. Reddy's Laboratories Fingolimod Product Portfolio
  36. 7.6.5 Dr. Reddy's Laboratories Recent Developments
  37. 7.7 BNF - NICE
  38. 7.7.1 BNF - NICE Company Information
  39. 7.7.2 BNF - NICE Business Overview
  40. 7.7.3 BNF - NICE Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 BNF - NICE Fingolimod Product Portfolio
  42. 7.7.5 BNF - NICE Recent Developments
  43. 7.8 Arrow
  44. 7.8.1 Arrow Company Information
  45. 7.8.2 Arrow Business Overview
  46. 7.8.3 Arrow Fingolimod Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Arrow Fingolimod Product Portfolio
  48. 7.8.5 Arrow Recent Developments
8 North America
  1. 8.1 North America Fingolimod Market Size by Type
  2. 8.1.1 North America Fingolimod Revenue by Type (2021-2032)
  3. 8.1.2 North America Fingolimod Sales by Type (2021-2032)
  4. 8.1.3 North America Fingolimod Price by Type (2021-2032)
  5. 8.2 North America Fingolimod Market Size by Application
  6. 8.2.1 North America Fingolimod Revenue by Application (2021-2032)
  7. 8.2.2 North America Fingolimod Sales by Application (2021-2032)
  8. 8.2.3 North America Fingolimod Price by Application (2021-2032)
  9. 8.3 North America Fingolimod Market Size by Country
  10. 8.3.1 North America Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Fingolimod Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Fingolimod Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Fingolimod Market Size by Type
  2. 9.1.1 Europe Fingolimod Revenue by Type (2021-2032)
  3. 9.1.2 Europe Fingolimod Sales by Type (2021-2032)
  4. 9.1.3 Europe Fingolimod Price by Type (2021-2032)
  5. 9.2 Europe Fingolimod Market Size by Application
  6. 9.2.1 Europe Fingolimod Revenue by Application (2021-2032)
  7. 9.2.2 Europe Fingolimod Sales by Application (2021-2032)
  8. 9.2.3 Europe Fingolimod Price by Application (2021-2032)
  9. 9.3 Europe Fingolimod Market Size by Country
  10. 9.3.1 Europe Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Fingolimod Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Fingolimod Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Fingolimod Market Size by Type
  2. 10.1.1 China Fingolimod Revenue by Type (2021-2032)
  3. 10.1.2 China Fingolimod Sales by Type (2021-2032)
  4. 10.1.3 China Fingolimod Price by Type (2021-2032)
  5. 10.2 China Fingolimod Market Size by Application
  6. 10.2.1 China Fingolimod Revenue by Application (2021-2032)
  7. 10.2.2 China Fingolimod Sales by Application (2021-2032)
  8. 10.2.3 China Fingolimod Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Fingolimod Market Size by Type
  2. 11.1.1 Asia Fingolimod Revenue by Type (2021-2032)
  3. 11.1.2 Asia Fingolimod Sales by Type (2021-2032)
  4. 11.1.3 Asia Fingolimod Price by Type (2021-2032)
  5. 11.2 Asia Fingolimod Market Size by Application
  6. 11.2.1 Asia Fingolimod Revenue by Application (2021-2032)
  7. 11.2.2 Asia Fingolimod Sales by Application (2021-2032)
  8. 11.2.3 Asia Fingolimod Price by Application (2021-2032)
  9. 11.3 Asia Fingolimod Market Size by Country
  10. 11.3.1 Asia Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Fingolimod Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Fingolimod Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Fingolimod Market Size by Type
  2. 12.1.1 SAMEA Fingolimod Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Fingolimod Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Fingolimod Price by Type (2021-2032)
  5. 12.2 SAMEA Fingolimod Market Size by Application
  6. 12.2.1 SAMEA Fingolimod Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Fingolimod Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Fingolimod Price by Application (2021-2032)
  9. 12.3 SAMEA Fingolimod Market Size by Country
  10. 12.3.1 SAMEA Fingolimod Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Fingolimod Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Fingolimod Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Fingolimod Value Chain Analysis
  2. 13.1.1 Fingolimod Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Fingolimod Production Mode & Process
  6. 13.2 Fingolimod Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Fingolimod Distributors
  9. 13.2.3 Fingolimod Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst